Redifferentiation of a BRAF K601E -Mutated Poorly Differentiated Thyroid Cancer Patient with Dabrafenib and Trametinib Treatment - Université Paris Cité Accéder directement au contenu
Article Dans Une Revue Thyroid Année : 2019

Redifferentiation of a BRAF K601E -Mutated Poorly Differentiated Thyroid Cancer Patient with Dabrafenib and Trametinib Treatment

Fichier non déposé

Dates et versions

hal-02399494 , version 1 (09-12-2019)

Identifiants

Citer

Sophie Leboulleux, Corinne Dupuy, Ludovic Lacroix, Marie Attard, Serena Grimaldi, et al.. Redifferentiation of a BRAF K601E -Mutated Poorly Differentiated Thyroid Cancer Patient with Dabrafenib and Trametinib Treatment. Thyroid, 2019, 29 (5), pp.735-742. ⟨10.1089/thy.2018.0457⟩. ⟨hal-02399494⟩
50 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More